W. Brian Dalton

2.0k total citations
32 papers, 1.1k citations indexed

About

W. Brian Dalton is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, W. Brian Dalton has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Hematology and 9 papers in Genetics. Recurrent topics in W. Brian Dalton's work include Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Microtubule and mitosis dynamics (6 papers). W. Brian Dalton is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Microtubule and mitosis dynamics (6 papers). W. Brian Dalton collaborates with scholars based in United States, China and Australia. W. Brian Dalton's co-authors include Vincent W. Yang, Mandayam O. Nandan, Amr M. Ghaleb, Sengthong Chanchevalap, Irfan M. Hisamuddin, Noelani Laycock, Holly C. Williams, David L. Jaye, Christopher D. Scharer and Pengbo Liu and has published in prestigious journals such as Blood, Hepatology and Cancer Research.

In The Last Decade

W. Brian Dalton

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Brian Dalton United States	14	857	258	224	185	148	32	1.1k
Roberto Bellelli United Kingdom	16	1.1k 1.2×	245 0.9×	68 0.3×	283 1.5×	97 0.7×	23	1.3k
Madeleine Carreau Canada	18	1.6k 1.8×	487 1.9×	273 1.2×	214 1.2×	195 1.3×	44	1.9k
Susan C. Evans United States	19	739 0.9×	117 0.5×	134 0.6×	265 1.4×	128 0.9×	28	1.1k
Lykourgos‐Panagiotis Zalmas United Kingdom	12	1.2k 1.4×	201 0.8×	81 0.4×	366 2.0×	131 0.9×	14	1.4k
Kyungsoo Ha United States	16	873 1.0×	88 0.3×	130 0.6×	240 1.3×	100 0.7×	31	1.1k
Amit J. Sabnis United States	13	562 0.7×	113 0.4×	72 0.3×	245 1.3×	105 0.7×	32	951
Cindy Wilson United States	12	705 0.8×	165 0.6×	385 1.7×	394 2.1×	67 0.5×	15	1.1k
Laura A. Rudolph‐Owen United States	10	763 0.9×	336 1.3×	113 0.5×	361 2.0×	81 0.5×	12	1.2k
Marco Cirò Italy	10	859 1.0×	225 0.9×	61 0.3×	320 1.7×	87 0.6×	11	1.1k
Johanna C. Scheuermann Germany	8	1.4k 1.6×	731 2.8×	100 0.4×	112 0.6×	100 0.7×	8	1.6k

Countries citing papers authored by W. Brian Dalton

Since Specialization

Citations

This map shows the geographic impact of W. Brian Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Brian Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Brian Dalton more than expected).

Fields of papers citing papers by W. Brian Dalton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Brian Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Brian Dalton. The network helps show where W. Brian Dalton may publish in the future.

Co-authorship network of co-authors of W. Brian Dalton

This figure shows the co-authorship network connecting the top 25 collaborators of W. Brian Dalton. A scholar is included among the top collaborators of W. Brian Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Brian Dalton. W. Brian Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mo, Shirley, Alexander J. Ambinder, Amy E. DeZern, et al.. (2025). DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors. Blood. 146(Supplement 1). 1710–1710.

Webster, Jonathan, Mark J. Levis, Ivana Gojo, et al.. (2025). Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML. PubMed. 2(4). 100133–100133. 1 indexed citations

Li, Daniel, B. Douglas Smith, Mark J. Levis, et al.. (2024). Efficacy and Tolerability of Blinatumomab in Clinical Trial Ineligible Patients with CD19+ Leukemias. Blood. 144(Supplement 1). 5904–5904.

Jain, Tania, W. Brian Dalton, Sergiu Paşca, et al.. (2023). Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia. Leukemia Research. 131. 107345–107345. 4 indexed citations

Sanber, Khaled, Hua‐Ling Tsai, Jonathan Webster, et al.. (2023). Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease. Leukemia & lymphoma. 64(4). 846–855. 3 indexed citations

Karantanos, Theodoros, Patric Teodorescu, Brandy Perkins, et al.. (2022). The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia. Science Advances. 8(7). eabl8952–eabl8952. 10 indexed citations

Karantanos, Theodoros, Hua‐Ling Tsai, Lukasz P. Gondek, et al.. (2022). Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Leukemia & lymphoma. 63(8). 1942–1948. 8 indexed citations

Karantanos, Theodoros, Patric Teodorescu, Marios Arvanitis, et al.. (2022). CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine. Haematologica. 108(7). 1886–1899. 8 indexed citations

Boleij, Annemarie, Payam Fathi, W. Brian Dalton, et al.. (2021). G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis. Communications Biology. 4(1). 585–585. 31 indexed citations

10.

Dalton, W. Brian, Bing Li, Christopher D. Gocke, et al.. (2020). The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing. Blood Advances. 4(7). 1192–1196. 38 indexed citations

11.

Croessmann, Sarah, Hong Yuen Wong, Daniel J. Zabransky, et al.. (2017). PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity. Breast Cancer Research and Treatment. 162(3). 451–464. 17 indexed citations

12.

Lee, Justin, Jennifer E. Axilbund, W. Brian Dalton, et al.. (2016). A Polycythemia VeraJAK2Mutation Masquerading as a Duodenal Cancer Mutation. Journal of the National Comprehensive Cancer Network. 14(12). 1495–1498. 10 indexed citations

13.

Yu, Bing, W. Brian Dalton, & Vincent W. Yang. (2012). CDK1 Regulates Mediator of DNA Damage Checkpoint 1 during Mitotic DNA Damage. Cancer Research. 72(21). 5448–5453. 13 indexed citations

14.

Dalton, W. Brian, Bing Yu, & Vincent W. Yang. (2010). p53 suppresses structural chromosome instability after mitotic arrest in human cells. Oncogene. 29(13). 1929–1940. 35 indexed citations

15.

Pannu, Vaishali, Kalpna Gupta, W. Brian Dalton, et al.. (2010). A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering. Cell Death and Differentiation. 18(4). 632–644. 60 indexed citations

16.

Hagos, Engda G., Amr M. Ghaleb, W. Brian Dalton, Agnieszka B. Bialkowska, & Vincent W. Yang. (2009). Mouse embryonic fibroblasts null for the Krüppel-like factor 4 gene are genetically unstable. Oncogene. 28(9). 1197–1205. 38 indexed citations

17.

Dalton, W. Brian, Mandayam O. Nandan, Ryan T. Moore, & Vincent W. Yang. (2007). Human Cancer Cells Commonly Acquire DNA Damage during Mitotic Arrest. Cancer Research. 67(24). 11487–11492. 70 indexed citations

18.

Liu, Pengbo, Sumathi Ramachandran, Mohamed Ali‐Seyed, et al.. (2006). Sex-Determining Region Y Box 4 Is a Transforming Oncogene in Human Prostate Cancer Cells. Cancer Research. 66(8). 4011–4019. 240 indexed citations

19.

Ghaleb, Amr M., Mandayam O. Nandan, Sengthong Chanchevalap, et al.. (2005). Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Research. 15(2). 92–96. 251 indexed citations

20.

Yoon, Hong Seok, Amr M. Ghaleb, Mandayam O. Nandan, et al.. (2005). Krüppel-like factor 4 prevents centrosome amplification following γ-irradiation-induced DNA damage. Oncogene. 24(25). 4017–4025. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact